Works matching DE "GILEAD Sciences Inc."

Results: 116

4-in-1 solution.

Published in:

Nature Reviews Microbiology, 2012, v. 10, n. 8, p. 522, doi. 10.1038/nrmicro2842

By:

David, Rachel

Publication type:

Article

Valuation of Corporate Innovation and the Pricing of Risk in the Biopharmaceutical Industry: The Case of Gilead.

Published in:

Journal of Applied Corporate Finance, 2018, v. 30, n. 2, p. 92, doi. 10.1111/jacf.12303

By:

Ottoo, Richard Ebil

Publication type:

Article

Pharmacologic hyperstabilisation of the HIV-1 capsid lattice induces capsid failure.

Published in:

eLife, 2024, p. 1, doi. 10.7554/eLife.83605

By:

Faysal, K. M. Rifat;
Walsh, James C.;
Renner, Nadine;
Márquez, Chantal L.;
Shah, Vaibhav B.;
Tuckwell, Andrew J.;
Christie, Michelle P.;
Parker, Michael W.;
Turville, Stuart G.;
Towers, Greg J.;
James, Leo C.;
Jacques, David A.;
Böcking, Till

Publication type:

Article

THE WEATHERVANE.

Published in:: Hawaii Journal of Medicine & Public Health, 2013, v. 72, n. 1, p. 34
Publication type:: Article

The Elegance of the Acyclic Nucleoside Phosphonates (ANPs), Honorary Tribute to Antonín Holý, Who Passed Away on 16 July 2012, at the 10th Anniversary of His Death.

Published in:

Viruses (1999-4915), 2022, v. 14, n. 9, p. 1978, doi. 10.3390/v14091978

By:

De Clercq, Erik

Publication type:

Article

Tribute to John C. Martin at the Twentieth Anniversary of the Breakthrough of Tenofovir in the Treatment of HIV Infections.

Published in:

Viruses (1999-4915), 2021, v. 13, n. 12, p. 2410, doi. 10.3390/v13122410

By:

De Clercq, Erik

Publication type:

Article

Niche indications could drive higher valuations.

Published in:

Nature Biotechnology, 2006, v. 24, n. 12, p. 1457, doi. 10.1038/nbt1206-1457

By:

Ransom, John

Publication type:

Article

Is there balm in Gilead?

Published in:

2006

By:

Jacobs, Tom

Publication type:

Editorial

Cash-strapped biotechs find financing alternative.

Published in:

Nature Biotechnology, 2004, v. 22, n. 9, p. 1057, doi. 10.1038/nbt0904-1057

By:

Mitchell, Peter

Publication type:

Article

Gilead acquires NeXstar.

Published in:

Nature Biotechnology, 1999, v. 17, n. 4, p. 316, doi. 10.1038/7841

By:

Dorey, Emma

Publication type:

Article

AIDS Drug Approved to Treat Hepatitis B Infection.

Published in:: Clinical Infectious Diseases, 2008, v. 47, n. 8, p. iv
Publication type:: Article

FDA PANEL UNANIMOUSLY ENDORSES ADEFOVIR DIPIVOXIL FOR HEPATITIS B.

Published in:: Clinical Infectious Diseases, 2002, v. 35, n. 7, p. 2
Publication type:: Article

Approved indication: hepatitis C.

Published in:: 2014
Publication type:: Product Review

Foreword: Oseltamivir for seasonal, avian and pandemic influenza: 10 years of clinical experience.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2010, v. 65, n. suppl_2, p. ii3, doi. 10.1093/jac/dkq033

By:

Nguyen-Van-Tam, Jonathan S.

Publication type:

Article

Phase III.

Published in:: Applied Clinical Trials, 2005, v. 14, n. 9, p. 18
Publication type:: Article

Business News.

Published in:: Applied Clinical Trials, 2003, v. 12, n. 1, p. 62
Publication type:: Article

Phase 3 trials.

Published in:: Applied Clinical Trials, 2002, v. 11, n. 11, p. 64
Publication type:: Article

Ethical drug updates.

Published in:: 2016
Publication type:: Product Review

ETHICAL PRODUCTS.

Published in:: 2010
Publication type:: Product Review

Available Evidence and Ongoing Clinical Trials of Remdesivir: Could It Be a Promising Therapeutic Option for COVID-19?

Published in:

Frontiers in Pharmacology, 2020, v. 11, p. 1, doi. 10.3389/fphar.2020.00791

By:

Sisay, Mekonnen

Publication type:

Article

Clinical Cases in Hepatitis: Towards improving liver disease management in Australia.

Published in:

Journal of Gastroenterology & Hepatology, 2019, v. 34, p. 5, doi. 10.1111/jgh.14720

By:

Strasser, Simone I;
Thompson, Alexander J;
Roberts, Stuart K;
George, Jacob

Publication type:

Article

Clinical Experience with Use of Remdesivir in the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2: a Case Series.

Published in:

Infection & Chemotherapy, 2020, v. 52, n. 3, p. 369, doi. 10.3947/ic.2020.52.3.369

By:

Choongman Lee;
Mi Young Ahn;
Kyeongmin Byeon;
Jae-Phil Choi;
Chorom Hahm;
Hyeonmok Kim;
Suhyun Kim;
Tae Ho Kim;
JungKyun Oh;
Dong Hyun Oh

Publication type:

Article

There is a balm in Gilead: Idenix's patent infringed but invalid.

Published in:

Journal of Intellectual Property Law & Practice, 2015, v. 10, n. 6, p. 392, doi. 10.1093/jiplp/jpv044

By:

Smyth, Darren;
Barker, Robert

Publication type:

Article

Antiviral Briefs.

Published in:: AIDS Patient Care & STDs, 2007, v. 21, n. 12, p. 987, doi. 10.1089/apc.2007.9964
Publication type:: Article

Antiviral Briefs.

Published in:: AIDS Patient Care & STDs, 2001, v. 15, n. 7, p. 399, doi. 10.1089/108729101750301951
Publication type:: Article

COMPASSIONATE USE FOR TENOFOVIR.

Published in:: AIDS Patient Care & STDs, 2000, v. 14, n. 2, p. 101
Publication type:: Article

NDA filed to treat refractory herpes.

Published in:: AIDS Patient Care & STDs, 1997, v. 11, n. 2, p. 103
Publication type:: Article

Pharmacia and Upjohn and Gilead Sciences receive European recommendations for cidofovir.

Published in:: AIDS Patient Care & STDs, 1997, v. 11, n. 2, p. 102
Publication type:: Article

Gilead science announces statistically significant antiviral activity against hepatitis B virus.

Published in:: AIDS Patient Care & STDs, 1996, v. 10, n. 6, p. 384
Publication type:: Article

Business digest.

Published in:: Chemistry & Industry, 2011, p. 14, doi. 10.1002/cind.7524_5.x
Publication type:: Article

HCV drug tops previous launch records.

Published in:: Nature Reviews Drug Discovery, 2014, v. 13, n. 6, p. 405, doi. 10.1038/nrd4356
Publication type:: Article

Court sides with generics company over Tamiflu patent.

Published in:: Nature Reviews Drug Discovery, 2014, v. 13, n. 6, p. 408, doi. 10.1038/nrd4352
Publication type:: Article

Market watch: Upcoming market catalysts in Q1 2014.

Published in:

Nature Reviews Drug Discovery, 2014, v. 13, n. 1, p. 11, doi. 10.1038/nrd4206

By:

Stopke, Edward

Publication type:

Article

Patent battle lines drawn as sofosbuvir gains approval.

Published in:

Nature Reviews Drug Discovery, 2014, v. 13, n. 1, p. 12, doi. 10.1038/nrd4220

By:

Harrison, Charlotte

Publication type:

Article

First-in-class PI3K inhibitor advances.

Published in:: Nature Reviews Drug Discovery, 2013, v. 12, n. 11, p. 817, doi. 10.1038/nrd4174
Publication type:: Article

All-oral HCV therapies near approval.

Published in:

Nature Reviews Drug Discovery, 2013, v. 12, n. 6, p. 409, doi. 10.1038/nrd4036

By:

Tse, Man Tsuey

Publication type:

Article

NEW TENOFOVIR FORMULATION WORKS EQUALLY WELL WITH LESS EFFECT ON KIDNEYS AND BONES.

Published in:

HIV Australia, 2013, v. 11, n. 3, p. 61

By:

Highleyman, Liz

Publication type:

Article

FDA decision on the approval of Truvada for PrEP delayed three months.

Published in:: HIV Australia, 2012, v. 10, n. 1, p. 4
Publication type:: Article

Controversy over Gilead licensing agreement.

Published in:: HIV Australia, 2011, v. 9, n. 2, p. 5
Publication type:: Article

MARKETPLACE.

Published in:: Oncology Exchange, 2015, v. 14, n. 4, p. 49
Publication type:: Article

Geographical and Historical Observations on the old North Israelite Gideon tale in Judges.

Published in:

Zeitschrift für die Alttestamentliche Wissenschaft, 2017, v. 129, n. 1, p. 1, doi. 10.1515/zaw-2017-0005

By:

Finkelstein, Israel;
Lipschits, Oded

Publication type:

Article

A New Focus on Prescription Drug Spending.

Published in:

JAMA: Journal of the American Medical Association, 2015, v. 314, n. 5, p. 440, doi. 10.1001/jama.2015.8733

By:

Wilensky, Gail

Publication type:

Article

New Expensive Treatments for Hepatitis C Infection.

Published in:

JAMA: Journal of the American Medical Association, 2014, v. 312, n. 6, p. 593, doi. 10.1001/jama.2014.8897

By:

Brennan, Troyen;
Shrank, William

Publication type:

Article

New HIV Drug Pricing.

Published in:

JAMA: Journal of the American Medical Association, 2012, v. 308, n. 14, p. 1421, doi. 10.1001/jama.2012.13452

By:

Mitka, Mike

Publication type:

Article

Intensive Models of Hepatitis C Care for People Who Inject Drugs Receiving Opioid Agonist Therapy: A Randomized Controlled Trial.

Published in:

2019

By:

Akiyama, Matthew J.;
Norton, Brianna L.;
Arnsten, Julia H.;
Agyemang, Linda;
Heo, Moonseong;
Litwin, Alain H.

Publication type:

journal article

Limited Access to New Hepatitis C Virus Treatment Under State Medicaid Programs.

Published in:

2015

By:

Canary, Lauren A.;
Klevens, Monina;
Holmberg, Scott D.

Publication type:

Opinion

Binding of Dumbbell Oligonucleotides to MoMuLV Reverse Transcriptase: Inhibitory Properties of RNase H Activity.

Published in:

E-Journal of Chemistry, 2010, v. 7, n. 3, p. 701, doi. 10.1155/2010/616512

By:

Kumar, Ajay

Publication type:

Article

Who Urges Action Over Growing Hepatitis Epidemic.

Published in:

Clinical Infectious Diseases, 2017, v. 65, n. 2, p. i

By:

Kaye, Donald

Publication type:

Article

Switching Course, Gilead Markets HIV Drug for Prevention.

Published in:

2017

By:

Kaye, Donald

Publication type:

Abstract

Gilead's Investigational Fixed-Dose Combination of Emtricitabine/Tenofovir Alafenamide Meets Primary 48-Week Objective in Phase 3 Study.

Published in:: Clinical Infectious Diseases, 2015, v. 61, n. 10, p. ii, doi. 10.1093/cid/civ853
Publication type:: Article